Active and onboarding programmes with Hekim İlaç include neuronal stress-pathway evaluation, comparative sleep-support studies, in vivo validation and future peptide-development routes.
Imperion Biotechnology is working with Hekim İlaç across multiple research and development directions, including neuroscience-linked formulation evaluation, in vivo validation and peptide-related development planning.
Current and planned programmes include neuronal stress-pathway assessment, sleep-support biology, corticosterone-induced neuronal stress modelling, circadian-pathway interpretation, behavioural outcome layers and future peptide-production development.
These programmes support a broader goal: generating structured biological evidence for product development through molecular, cellular and preclinical validation systems.